doi: 10.1038/ng.3796.
The road to precision oncology
Affiliations
- PMID: 28232728
- DOI: 10.1038/ng.3796
Item in Clipboard
The road to precision oncology
Nat Genet.
.
Free article
Abstract
The ultimate goal of precision medicine is to use population-based molecular, clinical and other data to make individually tailored clinical decisions for patients, although the path to achieving this goal is not entirely clear. A new study shows how knowledge banks of patient data can be used to make individual treatment decisions in acute myeloid leukemia.
Similar articles
-
Effect of allogeneic hematopoietic cell transplantation in first complete remission on post-relapse complete remission rate and survival in acute myeloid leukemia.Haematologica. 2015 Jul;100(7):e254-6. doi: 10.3324/haematol.2014.118570. Epub 2015 Mar 20. Haematologica. 2015. PMID: 25795719 Free PMC article. No abstract available.
-
Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT.Haematologica. 2016 Feb;101(2):248-55. doi: 10.3324/haematol.2015.132654. Epub 2015 Nov 20. Haematologica. 2016. PMID: 26589909 Free PMC article.
-
The Changing Landscape of Treatment in Acute Myeloid Leukemia.Am Soc Clin Oncol Educ Book. 2020 Mar;40:1-12. doi: 10.1200/EDBK_279129. Am Soc Clin Oncol Educ Book. 2020. PMID: 32239961 Review.
-
Should persons with acute myeloid leukemia (AML) in 1st histological complete remission who are measurable residual disease (MRD) test positive receive an allotransplant?Leukemia. 2020 Apr;34(4):963-965. doi: 10.1038/s41375-020-0780-6. Epub 2020 Mar 4. Leukemia. 2020. PMID: 32132654 Review. No abstract available.
-
Choosing for whom to recommend allogeneic transplantation for acute myeloid leukemia in CR1: a continued, complicated conversation.Blood Adv. 2018 Jan 23;2(2):164. doi: 10.1182/bloodadvances.2017007674. Blood Adv. 2018. PMID: 29365325 Free PMC article. No abstract available.
Cited by
-
H3Africa: current perspectives.Pharmgenomics Pers Med. 2018 Apr 10;11:59-66. doi: 10.2147/PGPM.S141546. eCollection 2018. Pharmgenomics Pers Med. 2018. PMID: 29692621 Free PMC article. Review.
-
Shifting, overlapping and expanding use of "precision oncology" terminology: a retrospective literature analysis.BMJ Open. 2020 Jun 7;10(6):e036357. doi: 10.1136/bmjopen-2019-036357. BMJ Open. 2020. PMID: 32513891 Free PMC article.
-
Exploring the OncoGenomic Landscape of cancer.Genome Med. 2018 Aug 3;10(1):61. doi: 10.1186/s13073-018-0571-0. Genome Med. 2018. PMID: 30071882 Free PMC article.
-
Precision therapy for acute myeloid leukemia.J Hematol Oncol. 2018 Jan 5;11(1):3. doi: 10.1186/s13045-017-0543-7. J Hematol Oncol. 2018. PMID: 29301553 Free PMC article. Review.
-
Precision oncology: a review to assess interpretability in several explainable methods.Brief Bioinform. 2023 Jul 20;24(4):bbad200. doi: 10.1093/bib/bbad200. Brief Bioinform. 2023. PMID: 37253690 Free PMC article. Review.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
